Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a, Open-Label, Multicenter, Activity and Safety Study of KX2-391 Ointment 1% in Subjects With Actinic Keratosis on the Face or Scalp

NCT02838628 is registered in ClinicalTrials.gov with Almirall, S.A. as lead sponsor.

NCT NCT02838628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02838628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a, Open-Label, Multicenter, Activity and Safety Study of KX2-391 Ointment 1% in Subjects With Actinic Keratosis on the Face or Scalp
Lead sponsor
Almirall, S.A.
Phase
Phase 2
Overall status
Completed
Start date
April 11, 2016
Completion date
December 22, 2017
Enrollment
168 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis